These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 8786624

  • 1. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T, Tateda E, Hiramatsu K, Yokota T.
    Jpn J Antibiot; 1996 Apr; 49(4):324-37. PubMed ID: 8786624
    [Abstract] [Full Text] [Related]

  • 2. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria.
    Zhanel GG, Pozdirca M, Golden AR, Lawrence CK, Zelenitsky S, Berry L, Schweizer F, Bay D, Adam H, Zhanel MA, Lagacé-Wiens P, Walkty A, Irfan N, Naber K, Lynch JP, Karlowsky JA.
    Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC, Chin NX, Neu NM.
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [Abstract] [Full Text] [Related]

  • 4. [In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
    Nagashima M, Goto S, Yoshida T, Matsunaga T, Shimohira H, Ogawa M.
    Jpn J Antibiot; 1996 Apr; 49(4):303-23. PubMed ID: 8786623
    [Abstract] [Full Text] [Related]

  • 5. [Antibacterial activity of sulopenem, a new parenteral penem antibiotic].
    Inoue E, Komoto E, Taniyama Y, Mitsuhashi S.
    Jpn J Antibiot; 1996 Apr; 49(4):338-51. PubMed ID: 8786625
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages.
    Yokota T, Suzuki E, Arai K.
    Drugs Exp Clin Res; 1988 Apr; 14(8):495-500. PubMed ID: 3073932
    [Abstract] [Full Text] [Related]

  • 8. Review of the in vitro spectrum of activity of imipenem.
    Jones RN.
    Am J Med; 1985 Jun 07; 78(6A):22-32. PubMed ID: 3890537
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y, Inoue M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1987 Jul 07; 31(7):1085-92. PubMed ID: 3310868
    [Abstract] [Full Text] [Related]

  • 10. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Shigeta S, Takahashi T, Shiraiwa Y, Ogiwara M, Yoshida H, Imafuku Y, Murai M, Watanabe K, Uchida H, Kobayashi Y, Matsuda S, Fujime M, Fujita K, Igari J, Oguri T, Yamaguchi K, Matsumoto T, Kashitani F, Kaku M, Ooe H, Mochida C.
    Jpn J Antibiot; 1998 Feb 07; 51(2):69-111. PubMed ID: 9575437
    [Abstract] [Full Text] [Related]

  • 11. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J, Oguri T, Hiramatsu N, Akiyama K, Koyama T.
    Jpn J Antibiot; 2003 Oct 07; 56(5):458-96. PubMed ID: 14692381
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
    Arisawa M, Sekine Y, Shimizu S, Takano H, Angehrn P, Then RL.
    Antimicrob Agents Chemother; 1991 Apr 07; 35(4):653-9. PubMed ID: 1906261
    [Abstract] [Full Text] [Related]

  • 13. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y, Tsukamoto T, Hirose T, Yokoo A, Fujime M, Fujita K, Shigeta S, Watanabe J, Igari J, Ogiwara M, Ishibashi K, Oguri T, Yoshida H, Imafuku Y, Yamaguchi K, Matsumoto T, Kashitani F, Murai M, Ooe H, Nishikawa M, Watanabe K, Kobayashi Y, Uchida H, Oka T, Mochida C.
    Jpn J Antibiot; 1999 Feb 07; 52(2):93-129. PubMed ID: 10221177
    [Abstract] [Full Text] [Related]

  • 14. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams.
    Gunkel AG, Hechler U, Martin HH.
    J Gen Microbiol; 1991 Feb 07; 137(2):243-52. PubMed ID: 2016583
    [Abstract] [Full Text] [Related]

  • 15. Target affinities of faropenem to and its impact on the morphology of gram-positive and gram-negative bacteria.
    Dalhoff A, Nasu T, Okamoto K.
    Chemotherapy; 2003 Jul 07; 49(4):172-83. PubMed ID: 12886052
    [Abstract] [Full Text] [Related]

  • 16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Tazaki H, Iri H.
    Jpn J Antibiot; 1995 Nov 07; 48(11):1757-87. PubMed ID: 8558757
    [Abstract] [Full Text] [Related]

  • 17. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R, Altamura M, Arcamone F, Mazzariol A, Morandotti G, Sperning R, Cornaglia G.
    J Antimicrob Chemother; 1998 May 07; 41(5):513-25. PubMed ID: 9630405
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of HRE 664, a penem antibiotic.
    Chin XN, Neu HC.
    Diagn Microbiol Infect Dis; 1990 May 07; 13(6):509-16. PubMed ID: 2279381
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
    Gootz T, Retsema J, Girard A, Hamanaka E, Anderson M, Sokolowski S.
    Antimicrob Agents Chemother; 1989 Aug 07; 33(8):1160-6. PubMed ID: 2679370
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo antibacterial activities of FK037, a new parenteral cephalosporin.
    Nishino T, Otsuki M, Hatano K, Nishihara Y.
    Chemotherapy; 1994 Aug 07; 40(3):167-82. PubMed ID: 8205935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.